Measure
EEG · QEEG · ERP
- Person
- Sensors
- Recorded data
A measurement describes a recording. It does not by itself train a skill, diagnose a condition, or deliver stimulation.
Explore technologies, examine primary sources, and build a more informed clinical conversation.

The screen is the visible part. Behind it, the provider is selecting a signal feature, checking its quality, and connecting the training to a meaningful goal.
Scalp sensors read the selected EEG signal.
Software turns a chosen signal feature into a training rule.
A sound, image, or activity changes when the rule is met.
You practice while the provider watches signal quality and your response.
Important distinction: In conventional EEG neurofeedback, the scalp sensors record activity. They do not send electricity into the brain. Stimulation methods work differently.
A practical foundation for patients and clinicians beginning to explore these approaches.
Start with what crosses the boundary between the person and the technology. The categories can be combined in research, but they answer different questions.
EEG · QEEG · ERP
A measurement describes a recording. It does not by itself train a skill, diagnose a condition, or deliver stimulation.
Neurofeedback · HRV biofeedback
A measured signal changes sound, images, or another cue during practice. Meaningful outcomes still need to be tracked beyond the screen.
PBM · TMS · PEMF
Light or magnetic energy is applied using a defined protocol. Device, dose, target, screening, and evidence for the intended use all matter.
When categories combine: EEG-timed TMS, for example, uses a measurement to help time stimulation. Naming both parts is clearer than treating every brain technology as the same kind of intervention.
An amplifier makes the tiny signals readable. Software selects a feature, such as activity within a frequency band, and changes a sound or picture when the training criterion is met. Repeated feedback creates an opportunity for learning. In conventional EEG neurofeedback, the recording sensors do not deliver electricity to the brain.
You sit with sensors or a cap while watching or listening to feedback. A provider checks signal quality and adjusts the session. You do not need to understand the EEG trace or consciously control each brainwave. Visits also include preparation and discussion, so appointment length is different from training time.
The intended change is better functioning outside the session. Track agreed goals, such as sleep or attention, alongside signal learning. Evidence varies by protocol and condition. Improvement on a screen alone cannot establish benefit. Report headache, fatigue, irritability or sleep changes so the provider can reassess the plan.
What signal are we training, why was it selected, and how will we decide whether it helps me?
Software can summarize the strength of different rhythms or relationships between recording sites. Some reports compare these measures with a reference population. A colored map is a statistical display. It is not a photograph of the brain, and a color by itself is not a diagnosis.
A provider places sensors, often in a cap, checks contact quality and records under specified conditions, such as eyes open or closed. Eye movements, jaw tension and movement can contaminate the signal and must be identified before interpretation.
Sensors capture scalp EEG while the person follows instructions such as resting with eyes open or closed.
Eye movement, jaw tension, loose contacts and other artifacts must be identified before calculations are trusted.
Software can calculate rhythm strength, timing or relationships between recording sites.
Some reports compare selected measures with a reference population. The database and recording method matter.
The recording is considered alongside history, symptoms, other assessments and the question that prompted the test.
A color map is a statistical summary, not a photograph or diagnosis. A useful interpretation depends on recording quality, suitable comparisons and the person’s broader clinical picture.
Ask about recording conditions, reference choice, artifact handling and the comparison database. Medication, sleep and alertness can affect interpretation. A 19-channel assessment samples multiple scalp locations, but its usefulness depends on a sound recording and a clinically appropriate question.
How does this report fit with my history and assessment, and what will it change about the plan?
A small-channel protocol may focus on selected scalp locations. A larger array can support broader measurements or calculations across sites. The number of recording channels, the number of sensors and the number of features used for feedback are different specifications.
Setup may involve individual leads or a cap. More recording sites can mean more contact checks and more signals for the provider to inspect. A 19-channel QEEG assessment does not necessarily mean every training session uses 19 channels.
Channel count describes how many EEG signals can be processed at the same time. Sensors, recording locations and feedback features are separate specifications.
Each added recording site brings another contact and signal to inspect for movement, muscle activity and other artifacts.
A provider may use only selected channels or features for training. A 19-channel assessment does not mean all 19 channels are trained.
More channels can support broader measurement and calculations, but they do not by themselves establish a better clinical result.
More channels can add information and setup work, not automatic effectiveness. The number of sensors, processed channels and features used for feedback are related but different.
Choose an approach around the assessment question, signal quality and supporting evidence. ISNR encourages newcomers to develop competence in simpler power-training methods before progressing to more complex approaches. More channels do not establish superiority for an individual patient.
How many channels are recorded and actually used for feedback, and why is that appropriate for my goals?
Software repeatedly compares selected EEG features with a normative database. Feedback responds to the criteria chosen by the practitioner. This differs from rewarding a fixed amount of activity in one frequency band. The database, age matching and selected measures all matter.
The experience may look much like other neurofeedback: sensors, sound or visual feedback, and repeated practice. Ask the provider to explain what the comparison means in ordinary language.
The provider identifies selected EEG features and an appropriate age-matched reference database.
Software expresses how far each selected measure sits from the reference average in standard-deviation units.
The practitioner chooses which measures and thresholds affect the sound, image or other feedback cue.
Training is considered alongside symptoms, functioning, tolerability and goals that matter away from the screen.
A Z-score is a comparison, not a diagnosis or a universal treatment target. Movement toward the reference average does not by itself establish better health or daily functioning.
A reference average is not a universal treatment target. Movement toward it does not automatically establish improved health. The library includes a randomized trial with some favorable comparisons and mixed overall results, making symptom and functional tracking essential.
Which database and EEG measures are used, and how do we connect the target to an outcome that matters to me?
Source estimation works backward from scalp measurements to a possible distribution of activity within the brain. Source-based neurofeedback can use a selected estimated region or relationship between regions for feedback. The result depends on the model and quality of the recording.
A multi-sensor recording supplies the model. You may see ordinary audiovisual feedback rather than the source map. The clinician selects the estimated feature to train and monitors the recording for contamination.
A multi-sensor EEG captures electrical activity at the scalp under defined recording conditions.
The provider reviews contacts, movement, muscle activity and other artifacts before modeling the signal.
sLORETA, eLORETA or swLORETA uses mathematical assumptions to estimate a possible distribution of activity.
A selected source estimate or relationship may guide ordinary audiovisual feedback during practice.
A source map is a model-based estimate, not a direct measurement from inside the brain. sLORETA, eLORETA and swLORETA are related but not interchangeable, and source-based training is not automatically superior.
The methods are related but not interchangeable. A detailed-looking map is still an estimate, not direct measurement from inside the brain. A study comparing sLORETA with conventional neurofeedback for tinnitus did not establish superiority of source-based training.
Which source method is used, what does it estimate, and what evidence supports this particular training target?
A compatible recording system and software process slow activity to drive feedback. Providers may individualize the training parameters and sensor placement. The proposed links between slow activity, regulation and symptoms remain an active area of study.
Feedback may be visual or auditory, and the provider asks about your response during and between visits. Ask how the system handles slow drift and other recording artifacts.
The system follows slow signal changes while the person sits or practices under the provider’s chosen recording conditions.
Movement, contact changes and other slow drift can resemble the activity of interest, so signal quality needs ongoing attention.
ISF and ILF labels describe related slow-frequency approaches, but software, processing and feedback rules can differ by protocol.
The provider adjusts the plan using tolerability, sleep, symptoms and daily-life functioning rather than a universal ideal frequency.
ISF and ILF are not automatically interchangeable protocols. Very slow signals are sensitive to drift and artifact, and one method or study population does not establish benefit across every approach.
Evidence is protocol-specific. The library includes promising clinical observations and a placebo-controlled healthy-adult ILF trial that found no significant advantage on tested outcomes. A result from one method or population should not be transferred to every ISF or ILF system.
Which exact ISF or ILF method is this, what is measured, and how will changes or unwanted effects be tracked?
The same kind of event is presented repeatedly. EEG segments are aligned to the event and commonly averaged to make small responses easier to detect. Names such as P300 describe a waveform feature, not a diagnosis.
You may listen to tones, watch images or respond to selected events while wearing EEG sensors. The task instructions, hearing or vision, attention and number of usable trials can all affect the result.
The protocol specifies a tone, picture or other event, what the person should do and the response the test is designed to examine.
EEG is recorded while the event occurs many times, with timing markers that connect each segment to the event.
Eye movement, muscle activity, missed events and other contamination are considered before the selected trials are combined.
Valid EEG segments are aligned to the event and commonly averaged so a small time-locked response can be easier to detect.
Features such as timing or amplitude are considered with the task, recording method, sensory factors, attention and usable trial count.
An ERP is a time-locked average, not a diagnosis or measure of intelligence. Its timing and size depend on the task, recording quality, sensory factors, attention and the number of usable trials.
ERP assessment is different from neurofeedback training. Its interpretation depends on the task and recording methods. A delayed or smaller response needs context; it cannot by itself explain a person’s symptoms or establish intelligence.
What task and response are being measured, and what question can this test reliably answer?
Heart rate variability, or HRV, concerns changes in timing between heartbeats. HRV biofeedback uses measured heart-rate patterns alongside breathing practice. A provider helps you observe how the pattern changes; the aim is not simply to make the heart beat as slowly as possible.
A sensor records the heart signal while you follow comfortable breathing guidance. The session may include practice with and without feedback. Muscle biofeedback instead uses sensors to help identify patterns of tension and relaxation.
A sensor records the changing intervals between heartbeats and checks whether the signal is usable.
The person follows a paced breathing cue without forcing a very slow or uncomfortable pattern.
Feedback shows how the measured heart-rate pattern changes during practice.
The provider connects the exercise with agreed goals and a practical plan for between-session practice.
The goal is not simply to make the heart beat as slowly as possible. HRV biofeedback pairs a measured signal with comfortable practice and outcomes that matter outside the session.
A consumer readiness score is not interchangeable with a transparent HRV measurement. Signal quality, measurement conditions and the intended outcome matter. Research on stress and anxiety is promising, but findings do not apply automatically to every device or condition.
Which body signal are we measuring, how is it calculated, and what should I practice between visits?
Researchers study how absorbed light may affect cellular energy processes, including mitochondrial activity, and related blood-flow and signaling pathways. These are proposed mechanisms whose relevance depends on the exposure and tissue. A biological mechanism alone does not demonstrate a clinical benefit.
A device delivers light for a specified period. Wavelength, intensity, exposure time, pulsing and placement all affect the exposure. Use the device-specific eye-protection and operating instructions; visible brightness does not tell you the dose reaching the brain.
Record the wavelength, delivery type and output specified for the device rather than relying on color or brightness alone.
Placement, treated area, session time, pulsing and distance all help define the protocol being delivered.
Use the operating instructions, eye protection and contraindication guidance for that exact device and application.
Compare human studies using a similar device, dose, placement, population and outcome instead of generalizing across all red-light products.
A wavelength or flashing rate does not define the full exposure. Placement, output, area, time, pulsing and device design matter, and a proposed cellular mechanism does not by itself establish clinical benefit.
Only part of the applied light reaches deeper tissue. Results from one light device, body location or study cannot be transferred to every red-light product. Ask about human clinical outcomes as well as laboratory mechanisms, and keep emerging brain applications distinct from established uses elsewhere.
What wavelength and dose are used, and which human study tested a comparable device, protocol and population?
The stimulation pattern, target and intensity influence the intervention. Theta-burst stimulation is one patterned form. Unlike feedback training, TMS applies a physical stimulus directly; some research systems use EEG to help time that stimulus.
You remain awake while a trained team positions the coil and delivers pulses. You may hear clicking and feel tapping or scalp discomfort. Screening includes relevant medical history, seizure risk and implanted devices; hearing protection is used.
Name the condition, device and protocol, then separate an authorized use from an experimental target or schedule.
Review seizure risk, relevant medical history, medications and implanted or metallic devices before stimulation.
The trained team selects the target, intensity, pulse pattern and session schedule for the proposed use.
The person remains awake, uses hearing protection and reports tapping, discomfort, headache or other effects.
Track agreed clinical and daily-life outcomes alongside adverse effects, attendance and reasons to reconsider the plan.
TMS is stimulation, not feedback training. Authorization applies to specific devices and uses, while target, pulse pattern, screening and follow-up remain part of the clinical plan.
Some TMS devices have authorization for specific clinical uses. That does not authorize every target or protocol. Common effects can include headache or scalp discomfort; seizures are uncommon but a recognized risk. Device instructions and clinical screening govern use.
Which device and protocol are proposed, what is its authorization for this use, and how will benefit and tolerability be assessed?
A changing magnetic field can induce electrical effects in tissue. Exposure depends on the field, pulse pattern, coil geometry and distance. A label such as “10 Hz” describes repetition frequency and is not enough to compare two devices.
An applicator may be positioned near a selected body area. Duration and use instructions vary by device. Inform the provider about implanted electronic devices and follow the manufacturer’s contraindications.
Name the device, intended application and whether it delivers pulsed magnetic fields, TMS or a static magnetic field.
Field strength, pulse shape, repetition pattern, coil or applicator, distance and placement all help define what is delivered.
Follow the manufacturer’s instructions and review implants, medical conditions and other contraindications for that exact system.
Look for research using a comparable device, dose, target, population and outcome instead of generalizing across magnetic products.
A frequency such as 10 Hz does not define the full exposure. PEMF is a broad device class, is not the same as TMS or a static magnet, and evidence for one application does not validate every magnetic product.
PEMF and TMS should not be treated as equivalent treatments. Evidence for a bone-healing or pain application does not establish a brain-health benefit. Static magnets also differ from pulsed systems. The research library includes a specific depression study, not a class-wide endorsement.
What exact field and waveform reach the target, and is there evidence for this device and intended use?

Understand what EEG neurofeedback measures, what a first visit may involve, how to read the evidence, and how to choose and review care.

Meet the wider landscape of physiological feedback, including heart rate variability.

A field guide to reading device descriptions without treating every magnetic technology as interchangeable.

A practical checklist for discussing recording quality, interpretation, and next steps with your provider.

A repeatable framework for comparing tools, services, and the questions behind the claims.
Prepare for a useful first conversation.
0 of 6 discussion points prepared. Selections stay on this page only.
Primary references for your next question.
Educational resources here do not confer certification or continuing education credit.